ID   BJNhem20-OCIAD2-CRISPR-33
AC   CVCL_C6Q6
SY   JNCSRe002-A-1
DR   BioSamples; SAMEA110751570
DR   hPSCreg; JNCSRe002-A-1
DR   Wikidata; Q117704217
RX   PubMed=36642056;
CC   Population: Indian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 28685; OCIAD2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B843 ! BJNhem20
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
RX   PubMed=36642056; DOI=10.1016/j.scr.2023.103026;
RA   Kamat K., Inamdar M.S.;
RT   "Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33)
RT   and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic
RT   stem cell lines using CRISPR-Cas9 mediated targeting.";
RL   Stem Cell Res. 67:103026-103026(2023).
//